Phase III placebo-controlled double-blind randomized trial of radiotherapy for stage IIB–IVA cervical cancer with or without immunomodulator Z-100: a JGOG study-Reference-Cited by-同舟云学术

Phase III placebo-controlled double-blind randomized trial of radiotherapy for stage IIB–IVA cervical cancer with or without immunomodulator Z-100: a JGOG study

Published:2014-05 Issue:5 Volume:25 Page:1011-1017
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Sugiyama T.,Fujiwara K.,Ohashi Y.,Yokota H.,Hatae M.,Ohno T.,Nagai Y.,Mitsuhashi N.,Ochiai K.,Noda K.

Funder

ZERIA Pharmaceutical Co., Ltd

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/25/5/1011/24064505/mdu057.pdf

Reference15 articles.

1. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer;Rose;N Engl J Med,1999

2. Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: a systematic review and meta-analysis of individual patient data from 18 randomized trials;J Clin Oncol,2008

3. Phase III, open-label, randomized study comparing concurrent gemcitabine plus cisplatin and radiation followed by adjuvant gemcitabine and cisplatin versus concurrent cisplatin and radiation in patients with stage IIB to IVA carcinoma of the cervix;Duenas-Gonzalez;J Clin Oncol,2011

4. Phase I clinical trial of chemoimmunotherapy in combination with radiotherapy in stage IIIB cervical cancer patients;Wilailak;Int J Gynecol Cancer,2003

5. On the treatment of malignant tumor with an extract from tubercle bacilli (in Japanese);Maruyama;Jpn J Dermatol,1966

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A systematic review of stage IVA cervical cancer treatment: Challenges in the management of an understudied group;Gynecologic Oncology;2024-08

2. A comprehensive bibliometric analysis (2000–2022) on the mapping of knowledge regarding immunotherapeutic treatments for advanced, recurrent, or metastatic cervical cancer;Frontiers in Pharmacology;2024-05-10

3. Radiation-targeted immunotherapy: A new perspective in cancer radiotherapy;Cytokine & Growth Factor Reviews;2023-11

4. A nod to the bond between NOD2 and mycobacteria;PLOS Pathogens;2023-06-01

5. 次世代リーダーの育成―頭頸部癌に対する免疫療法の最前線―;Nippon Jibiinkoka Tokeibugeka Gakkai Kaiho(Tokyo);2023-02-20